Schedule 13D ownership disclosure

Orexigen Theraptcs

Security class unavailable · CUSIP: 686164302

Event date: 2018-04-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
37.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-18-019792
Form type
SC 13D/A
Filer
BAUPOST GROUP LLC/MA
CIK
CIK 1061768
Filed
Apr 26, 2018
Reporting period
Apr 13, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub